BR
Braxia Scientific Corp.
BRAXF · OTC
$0.00 +0.00% (+$0.00)
1M +9,900.00%
Market Cap $39.2K
P/E Ratio -
Div. Yield -
ROE -
Piotroski F-Score Weak
3/9Valuation
100 /100
Cheap P/B 0.02x
P/S 0.02x
EV/FFO N/A
Growth
78 /100
Growing Book val. growth 51.42%
Rev. growth 1,971.39%
FCF growth N/A
Profitability
1 /100
Weak Op. margin 397.00%
Gross margin 9.12%
FCF margin 440.60%
Quality
9 /100
Poor Asset turnover 0.49x
ROIC 408.30%
ROA 338.35%
Debt
55 /100
Moderate Int. coverage -743.78x
Debt/Equity 0.13x
Current ratio 1.00x
Stability
10 /100
Unstable EPS volatility 7,320.63%
Beta 1.45x
Profitable years 0
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o BRAXF
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Peter Rizakos
Employees
5
Headquarters
Toronto